RSPO4 and Hepatic fibrosis: A noteworthy finding was that the mRNA levels of RSPO4, α-SMA, and collagen-I in the CRISPR group are likely to close to those of the control, suggesting RSPO4-CRISPR may be able to reverse the progression of liver fibrosis.